260 related articles for article (PubMed ID: 18925456)
1. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population.
Hellman U; Alarcon F; Lundgren HE; Suhr OB; Bonaiti-Pellié C; Planté-Bordeneuve V
Amyloid; 2008 Sep; 15(3):181-6. PubMed ID: 18925456
[TBL] [Abstract][Full Text] [Related]
2. TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?
Bonaïti B; Olsson M; Hellman U; Suhr O; Bonaïti-Pellié C; Planté-Bordeneuve V
Eur J Hum Genet; 2010 Aug; 18(8):948-52. PubMed ID: 20234390
[TBL] [Abstract][Full Text] [Related]
3. On the origin of the transthyretin Val30Met familial amyloid polyneuropathy.
Zaros C; Genin E; Hellman U; Saporta MA; Languille L; Wadington-Cruz M; Suhr O; Misrahi M; Planté-Bordeneuve V
Ann Hum Genet; 2008 Jul; 72(Pt 4):478-84. PubMed ID: 18460047
[TBL] [Abstract][Full Text] [Related]
4. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y
Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan.
Sobue G; Koike H; Misu K; Hattori N; Yamamoto M; Ikeda S; Ando Y; Nakazato M; Inukai A
Amyloid; 2003 Aug; 10 Suppl 1():32-8. PubMed ID: 14640040
[TBL] [Abstract][Full Text] [Related]
6. A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers.
Olsson M; Norgren N; Obayashi K; Plante-Bordeneuve V; Suhr OB; Cederquist K; Jonasson J
BMC Med Genet; 2010 Sep; 11():130. PubMed ID: 20840742
[TBL] [Abstract][Full Text] [Related]
7. Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.
Rudolph T; Kurz MW; Farbu E
Clin Med Res; 2008 Sep; 6(2):80-2. PubMed ID: 18606975
[TBL] [Abstract][Full Text] [Related]
8. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.
Dardiotis E; Koutsou P; Zamba-Papanicolaou E; Vonta I; Hadjivassiliou M; Hadjigeorgiou G; Cariolou M; Christodoulou K; Kyriakides T
J Neurol Sci; 2009 Sep; 284(1-2):158-62. PubMed ID: 19493541
[TBL] [Abstract][Full Text] [Related]
9. Frequency of the transthyretin Val30Met mutation in the northern Swedish population.
Olsson M; Jonasson J; Cederquist K; Suhr OB
Amyloid; 2014 Mar; 21(1):18-20. PubMed ID: 24555660
[TBL] [Abstract][Full Text] [Related]
10. Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden.
Soares ML; Coelho T; Sousa A; Holmgren G; Saraiva MJ; Kastner DL; Buxbaum JN
Eur J Hum Genet; 2004 Mar; 12(3):225-37. PubMed ID: 14673473
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.
Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M
J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945
[TBL] [Abstract][Full Text] [Related]
12. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning?
Lopes A; Rodrigues C; Fonseca I; Sousa A; Branco M; Coelho T; Sequeiros J; Freitas P
Clin Genet; 2018 Nov; 94(5):401-408. PubMed ID: 30019395
[TBL] [Abstract][Full Text] [Related]
13. Penetrance estimation of TTR familial amyloid polyneuropathy (type I) in Brazilian families.
Saporta MA; Zaros C; Cruz MW; André C; Misrahi M; Bonaïti-Pellié C; Planté-Bordeneuve V
Eur J Neurol; 2009 Mar; 16(3):337-41. PubMed ID: 19364362
[TBL] [Abstract][Full Text] [Related]
14. New data on the genetic profile and penetrance of hereditary Val30Met transthyretin amyloidosis in Sweden.
Gorram F; Olsson M; Alarcon F; Nuel G; Anan I; Planté-Bordeneuve V
Amyloid; 2021 Jun; 28(2):84-90. PubMed ID: 33146042
[TBL] [Abstract][Full Text] [Related]
15. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
Ikeda S; Nakazato M; Ando Y; Sobue G
Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682
[TBL] [Abstract][Full Text] [Related]
16. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A
Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406
[TBL] [Abstract][Full Text] [Related]
17. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation.
Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A
Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035
[TBL] [Abstract][Full Text] [Related]
18. A Swedish family with the rare Phe33Leu transthyretin mutation.
Holmgren G; Hellman U; Jonasson J; Lundgren HE; Westermark P; Suhr OB
Amyloid; 2005 Sep; 12(3):189-92. PubMed ID: 16194875
[TBL] [Abstract][Full Text] [Related]
19. Large normal alleles of ATXN2 decrease age at onset in transthyretin familial amyloid polyneuropathy Val30Met patients.
Santos D; Coelho T; Alves-Ferreira M; Sequeiros J; Mendonça D; Alonso I; Sousa A; Lemos C
Ann Neurol; 2019 Feb; 85(2):251-258. PubMed ID: 30615214
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.
Hattori T; Takei Y; Koyama J; Nakazato M; Ikeda S
Amyloid; 2003 Dec; 10(4):229-39. PubMed ID: 14986482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
